|
At the end of the government’s beagle experiment, the contract says the dogs are “humanely sacrificed, necropsied, and telemetry transmitters recovered for refurbishing and future use.”
Read it again, Taxpayer.
The equipment gets saved. The dogs get thrown away.
That line isn’t ours. It’s the National Institute on Drug Abuse’s own statement of work, pulled off the government’s own contracting site by White Coat Waste. For contract #75N95024F00001, there is a $1,487,646 taxpayer-funded order to poison purpose-bred beagles with a drug the NIDA won’t even name.
And here’s the part that should have ended this argument years ago, Taxpayer: no law requires any of it.
HERE’S WHY: Congress already cut this red tape. The FDA Modernization Act 2.0 struck the animal-testing mandate out of federal law in 2022.
The FDA has said it flat out, on the record to WCW: “The FDA does not mandate that human drugs be studied in dogs.”
The mandate is gone. The spending isn’t.
WCW went through the awards that are still open right now. One of them runs out today:
NIDA → SRI International — $1,487,646: contract #75N95024F00001, described by the government in four words: “GLP SINGLE DOSE TOXICITY STUDY IN DOGS.” Clock runs out September 12.
NIDCR → RevBio, Inc. — $2,350,357: grant #R44DE029369, “A Novel Opioid-Free Targeted Pain Control Method for Acute Post-Operative Localized Pain Related to Oral Surgical Procedures.” Clock runs out September 18.
$3,838,003 of your tax dollars. Two federal deadlines. Two chances to say no.
|